Efficacy and safety of perampanel in Parkinson’s disease. A systematic review with meta-analysis


L-Dopa represents the mainstay of therapy of Parkinson’s disease (PD), but its effectiveness is reduced with continued treatment and disease progression. Accordingly, there remains a need to explore novel treatment strategies to manage the signs and symptoms of the later disease stages. The aim of the study was to evaluate the efficacy and safety of… (More)
DOI: 10.1007/s00415-017-8681-y


5 Figures and Tables